US 8138345
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
granted A61KA61K31/444A61K31/4709
Quick answer
US patent 8138345 (Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity) held by Theravance, Inc. expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Mar 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/444, A61K31/4709, A61K31/56, A61K45/06